Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

mTOR kinase structure, mechanism and regulation.

Authors:
Haijuan Yang Derek G Rudge Joseph D Koos Bhamini Vaidialingam Hyo J Yang Nikola P Pavletich

Nature 2013 May 1;497(7448):217-23. Epub 2013 May 1.

Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer. Here we report co-crystal structures of a complex of truncated mTOR and mammalian lethal with SEC13 protein 8 (mLST8) with an ATP transition state mimic and with ATP-site inhibitors. The structures reveal an intrinsically active kinase conformation, with catalytic residues and a catalytic mechanism remarkably similar to canonical protein kinases. The active site is highly recessed owing to the FKBP12-rapamycin-binding (FRB) domain and an inhibitory helix protruding from the catalytic cleft. mTOR-activating mutations map to the structural framework that holds these elements in place, indicating that the kinase is controlled by restricted access. In vitro biochemistry shows that the FRB domain acts as a gatekeeper, with its rapamycin-binding site interacting with substrates to grant them access to the restricted active site. Rapamycin-FKBP12 inhibits the kinase by directly blocking substrate recruitment and by further restricting active-site access. The structures also reveal active-site residues and conformational changes that underlie inhibitor potency and specificity.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512754PMC
May 2013

Publication Analysis

Top Keywords

frb domain
8
structures reveal
8
active site
8
intrinsically active
4
active kinase
4
reveal intrinsically
4
gatekeeper rapamycin-binding
4
vitro biochemistry
4
kinase directly
4
inhibits kinase
4
kinase conformation
4
residues catalytic
4
catalytic mechanism
4
catalytic residues
4
structural framework
4
conformation catalytic
4
inhibitors structures
4
atp-site inhibitors
4
acts gatekeeper
4
atp transition
4

Keyword Occurance

Similar Publications

Visualizing protein-protein interactions in plants by rapamycin-dependent delocalization.

Authors:
Joanna Winkler Evelien Mylle Andreas De Meyer Benjamin Pavie Julie Merchie Peter Grones Daniël Van Damme

Plant Cell 2021 Jan 25. Epub 2021 Jan 25.

Department of Plant Biotechnology and Bioinformatics, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.

Identifying protein-protein interactions (PPIs) is crucial for understanding biological processes. Many PPI tools are available, yet only some function within the context of a plant cell. Narrowing down even further, only a few tools allow complex multi-protein interactions to be visualized. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules.

Authors:
Serena Vittorio Rosaria Gitto Ilenia Adornato Emilio Russo Laura De Luca

Molecules 2021 Feb 19;26(4). Epub 2021 Feb 19.

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Palatucci 13, I-98168 Messina, Italy.

Computer aided drug-design methods proved to be powerful tools for the identification of new therapeutic agents. We employed a structure-based workflow to identify new inhibitors targeting mTOR kinase at rapamycin binding site. By combining molecular dynamics (MD) simulation and pharmacophore modelling, a simplified structure-based pharmacophore hypothesis was built starting from the FKBP12-rapamycin-FRB ternary complex retrieved from RCSB Protein Data Bank (PDB code 1FAP). Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Caffeine-Operated Synthetic Modules for Chemogenetic Control of Protein Activities by Life Style.

Authors:
Tianlu Wang Lian He Ji Jing Tien-Hung Lan Tingting Hong Fen Wang Yun Huang Guolin Ma Yubin Zhou

Adv Sci (Weinh) 2021 Feb 13;8(3):2002148. Epub 2020 Dec 13.

Center for Translational Cancer Research Institute of Biosciences and Technology Texas A&M University Houston TX 77030 USA.

A genetically encoded caffeine-operated synthetic module (COSMO) is introduced herein as a robust chemically induced dimerization (CID) system. COSMO enables chemogenetic manipulation of biological processes by caffeine and its metabolites, as well as caffeinated beverages, including coffee, tea, soda, and energy drinks. This CID tool, evolved from an anti-caffeine nanobody via cell-based high-throughput screening, permits caffeine-inducible gating of calcium channels, tumor killing via necroptosis, growth factors-independent activation of tyrosine receptor kinase signaling, and enhancement of nanobody-mediated antigen recognition for the severe acute respiratory distress coronavirus 2 (SARS-CoV-2) spike protein. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Single-Chain Lanthanide Luminescence Biosensors for Cell-Based Imaging and Screening of Protein-Protein Interactions.

Authors:
Ting Chen Ha Pham Ali Mohamadi Lawrence W Miller

iScience 2020 Sep 6;23(9):101533. Epub 2020 Sep 6.

Department of Chemistry, University of Illinois at Chicago, Chicago, IL, USA.

Lanthanide-based, Förster resonance energy transfer (LRET) biosensors enabled sensitive, time-gated luminescence (TGL) imaging or multiwell plate analysis of protein-protein interactions (PPIs) in living cells. We prepared stable cell lines that expressed polypeptides composed of an alpha helical linker flanked by a Tb(III) complex-binding domain, GFP, and two interacting domains at each terminus. The PPIs examined included those between FKBP12 and the rapamycin-binding domain of m-Tor (FRB) and between p53 (1-92) and HDM2 (1-128). Read More

View Article and Full-Text PDF
September 2020
Similar Publications

Effects of glycosylation on the bioactivity of rapamycin.

Authors:
Peng Zhang Lijuan Zhang Xin-Jing Yue Ya-Jie Tang Changsheng Wu Yue-Zhong Li

Appl Microbiol Biotechnol 2020 Nov 17;104(21):9125-9134. Epub 2020 Sep 17.

State Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.

The macrolactone rapamycin (RAP) presents a broad range of bioactivities, but its clinical applications are compromised due to the poor water solubility and low bioavailability, which could probably be overcome by glycosylation. In this study, we tested a set of promiscuous glycosyltransferases (GTs) to modify rapamycin with four different sugar donors. BsGT-1 displayed the best glycosylation activity with a preference for UDP-glucose, and the glycosylation happened at C-28 or C-40 of rapamycin, producing rapamycin-40-O-β-D-glucoside (RG1), and two new compounds rapamycin-28-O-β-D-glucoside (RG2) and rapamycin-28,40-O-β-D-diglucoside (RG3). Read More

View Article and Full-Text PDF
November 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap